Stay updated on ARO-APOC3 in Dyslipidemia Clinical Trial
Sign up to get notified when there's something new on the ARO-APOC3 in Dyslipidemia Clinical Trial page.
Latest updates to the ARO-APOC3 in Dyslipidemia Clinical Trial page
- Check7 days agoChange DetectedAdded Show glossary and updated metadata to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Replaced the previous indicators 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check42 days agoChange DetectedAdded a broad list of trial locations across the United States, Australia, Canada, and New Zealand, and updated the study status to Completed. These changes reflect the open-label extension and expanded site participation.SummaryDifference2%
- Check70 days agoChange DetectedRevision: v3.3.2 is displayed on the page, replacing v3.2.0.SummaryDifference0.0%
- Check77 days agoChange DetectedRemoved the government-funding notice warning that information may not be up to date, removing the explicit caveat about updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check92 days agoChange DetectedDifference0.3%
Stay in the know with updates to ARO-APOC3 in Dyslipidemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARO-APOC3 in Dyslipidemia Clinical Trial page.